Injectafer Lawsuit Filed Over Severe Hypophosphatemia From Iron Injection

|

According to allegations raised in a recent filed product liability lawsuit, Injectafer side effects resulted in severely low and damaging phosphorous levels after a North Carolina woman received the iron replacement injection.

The complaint (PDF) was filed by Celeste White late last month in the U.S. District Court for the Eastern District of Pennsylvania, naming Luitpold Pharmaceuticals, Inc., American Regent, Inc., Daiichi Sankyo, and Vifor Pharmaceuticals Management Ltd. as defendants.

Injectafer (ferric carboxymaltose) was approved for intravenous use by the FDA in 2013. It is an iron replacement intended to treat iron deficiency anemia in adult patients with an intolerance to oral iron supplementation and who have non-dialysis dependent chronic kidney disease.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

According to allegations raised in the Injectafer lawsuit, White was prescribed the drug in December 2014, after she was diagnosed as suffered from Iron Deficiency Anemia (IDA). She took the injections a total of six times, and indicates that side effects caused her to develop a condition known as severe hypophosphatemia (HPP).

“[P]laintiff was diagnosed with sustained severe hypophosphatemia due to phosphate wasting,” according to the lawsuit. “Her records indicate that this diagnosis was induced by the administration of Injectafer. She was forced to undergo routine and regular monitoring of her phosphorous levels.”

The lawsuit came less than a month after a study by researchers from Norway found that side effects of Injectafer increase the risk of HPP.

The lawsuit indicates the manufacturers knew, or should have known of the risks of HPP from Injectafer, but failed to provide adequate warning to the medical community or patients. It also notes that with the failure to warn of HPP, the label also fails to warn of the potential injuries which could result.

Hypophosphatemia (HPP) can lead to severe health complications, including:

  • Cardiac arrest
  • Respiratory failure
  • Seizures
  • Muscle weakness
  • Coma
  • Death

White presents claims of negligence, negligent failure to warn, negligent design defect, negligent misrepresentation, fraud, strict liability, breach of warranty, gross negligence and violation of consumer protection laws.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |test caption



1 Comments


Sarah
I’ve gone through the same nightmare. 4 hospital admissions, IV phosphorus at home around the clock and still unable to stabilize. It’s so unfair what they can do.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Roblox is facing a lawsuit from a Georgia mother who alleges the platform’s failure to implement adequate child safety measures allowed online predators to groom her young son.
Hearings over the validity of expert witnesses in hair relaxer cancer lawsuits will begin on April 1, 2026, when plaintiffs’ experts must convince the judge that their testimony linking the products to cancer is scientifically reliable enough to be presented to juries.